Search filters

List of works by Seiichiro Katagiri

A unique breast involvement detected by MRI-DWIBS in T cell acute lymphoblastic leukemia

scientific article published on 12 July 2019

Cardiac biopsy with intracardiac echocardiographic guidance for successful diagnosis of cardiac lymphoma

scientific article published on 09 July 2018

Combination of Ponatinib with Hedgehog Antagonist Vismodegib for Therapy-Resistant BCR-ABL1–Positive Leukemia ⬇️

scientific article published on January 14, 2013

Combination of the ABL kinase inhibitor imatinib with the Janus kinase 2 inhibitor TG101348 for targeting residual BCR-ABL-positive cells

scientific article

Diffuse large B-cell lymphoma resembling a metastatic liver tumour

scientific article published on 14 October 2014

Downregulated microRNA-148b in circulating PBMCs in chronic myeloid leukemia patients with undetectable minimal residual disease: a possible biomarker to discontinue imatinib safely

scientific article

Downregulation of Plasma miR-215 in Chronic Myeloid Leukemia Patients with Successful Discontinuation of Imatinib

scientific article published on 15 April 2016

Fatal Cyberlindnera fabianii fungemia in a patient with mixed phenotype acute leukemia after umbilical cord blood transplantation

scientific article

Genetic variations of bone marrow mesenchymal stromal cells derived from acute leukemia and myelodysplastic syndrome by targeted deep sequencing.

scientific article published on 21 September 2017

Hidden FLT3-D835Y clone in FLT3-ITD-positive acute myeloid leukemia that evolved into very late relapse with T-lymphoblastic leukemia

scientific article published on 03 October 2017

Long-term remission of acquired von Willebrand syndrome associated with multiple myeloma using bortezomib and dexamethasone therapy.

scientific article published on 19 September 2016

Low body weight and body mass index may be associated with musculoskeletal pain following imatinib discontinuation in chronic myeloid leukemia

scientific article

Maintenance 5-azacytidine therapy by MRD monitoring after allogeneic HSCT in myeloid/lymphoid neoplasms with FGFR1 rearrangement

scientific article published on 22 January 2019

Overexpression of RUNX3 represses RUNX1 to drive transformation of myelodysplastic syndrome

scientific article published on 27 April 2020

Predisposed genomic instability in pre-treatment bone marrow evolves to therapy-related myeloid neoplasms in malignant lymphoma

scientific article published on 07 November 2019

Successful cord blood transplantation for myelodysplastic syndrome complicated by Mycobacterium kansasii pneumonia

scientific article published on 12 September 2020

Successful treatment with gilteritinib for initially FMS-like tyrosine kinase 3 gene internal tandem duplications-positive elderly refractory acute myeloid leukemia that changed into FMS-like tyrosine kinase 3 gene tyrosine kinase domain-positive af

scientific article published on 01 October 2019

Teriflunomide restores 5-azacytidine sensitivity via activation of pyrimidine salvage in 5-azacytidine-resistant leukemia cells

scientific article published on 22 July 2017

The BCL2L11 (BIM) deletion polymorphism is a possible criterion for discontinuation of imatinib in chronic myeloid leukaemia patients

scientific article published on 01 November 2012

Very late relapse with rapid BCR-ABL1 elevation after more than seven years of treatment-free remission with undetectable molecular residual disease in chronic myeloid leukaemia

scientific article published on 08 November 2019

[Treatment-free molecular remission achieved by combination therapy with imatinib and IFNα in CML with BIM deletion polymorphism relapsed after stop imatinib]

scientific article published on 01 February 2015

Paulina is supported by:

About Paulina

Help